Literature DB >> 1443300

The reporting of HIV/AIDS deaths in women.

J W Buehler1, D L Hanson, S Y Chu.   

Abstract

OBJECTIVE: This study was undertaken to assess the completeness of vital statistics and case reports of acquired immunodeficiency syndrome (AIDS) in measuring human immunodeficiency virus (HIV)-related mortality in women 15 through 44 years of age.
METHODS: We used vital records to determine the number of deaths attributed to HIV infection and excess deaths due to causes that have increased in tandem with the HIV epidemic.
RESULTS: In 1988, among women 15 through 44 years of age, there were 1365 deaths with HIV infection listed as the underlying cause, 202 deaths with HIV infection listed as an associated cause, and 149 excess deaths due to conditions highly associated with HIV infection (subtotal = 1716). In addition, there were 780 excess deaths due to causes that may be related to HIV infection or illicit drug use (maximum estimate of HIV-related deaths = 2496). Of the deaths that occurred in 1988, 1532 were reported through AIDS surveillance (1668 deaths when adjusted for reporting delays).
CONCLUSIONS: Underlying-cause-of-death vital records and AIDS surveillance identified 55% to 80% and 67% to 97%, respectively, of HIV-related deaths in women 15 through 44 years of age in 1988. The wide ranges of these estimates reflect the potential role of both HIV infection and drug use in contributing to excess mortality.

Entities:  

Mesh:

Year:  1992        PMID: 1443300      PMCID: PMC1694604          DOI: 10.2105/ajph.82.11.1500

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Injection drug use, mortality, and the AIDS epidemic.

Authors:  P A Selwyn
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

2.  Impact of the 1987 revision of the case definition of acquired immune deficiency syndrome in the United States.

Authors:  R M Selik; J W Buehler; J M Karon; M E Chamberland; R L Berkelman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

3.  Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program.

Authors:  P A Selwyn; D Hartel; W Wasserman; E Drucker
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

4.  Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital.

Authors:  A E O'Donnell; L S Pappas
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

5.  Staphylococcal sepsis precipitated by cocaine sniffing.

Authors:  H S Silverman; A L Smith
Journal:  N Engl J Med       Date:  1985-06-27       Impact factor: 91.245

6.  Impact of the human immunodeficiency virus epidemic on mortality trends in young men, United States.

Authors:  J W Buehler; O J Devine; R L Berkelman; F M Chevarley
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

7.  High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection.

Authors:  S H Vermund; K F Kelley; R S Klein; A R Feingold; K Schreiber; G Munk; R D Burk
Journal:  Am J Obstet Gynecol       Date:  1991-08       Impact factor: 8.661

8.  Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.

Authors:  P A Selwyn; A R Feingold; D Hartel; E E Schoenbaum; M H Alderman; R S Klein; G H Friedland
Journal:  AIDS       Date:  1988-08       Impact factor: 4.177

Review 9.  HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi's sarcoma.

Authors:  C S Rabkin; W A Blattner
Journal:  Cancer Surv       Date:  1991

10.  High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women.

Authors:  J C Johnson; A F Burnett; G D Willet; M A Young; J Doniger
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

View more
  5 in total

1.  Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa.

Authors:  F Sitas; W R Bezwoda; V Levin; P Ruff; M C Kew; M J Hale; H Carrara; V Beral; G Fleming; R Odes; A Weaving
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996.

Authors:  Robert S Levine; Nathaniel C Briggs; Barbara S Kilbourne; William D King; Yvonne Fry-Johnson; Peter T Baltrus; Baqar A Husaini; George S Rust
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

3.  Causes of death among persons reported with AIDS.

Authors:  S Y Chu; J W Buehler; L Lieb; G Beckett; L Conti; S Costa; B Dahan; R Danila; E J Fordyce; A Hirozawa
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

4.  Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.

Authors:  Mardge H Cohen; Audrey L French; Lorie Benning; Andrea Kovacs; Kathryn Anastos; Mary Young; Howard Minkoff; Nancy A Hessol
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

5.  Model Programs Addressing Perinatal Drug Exposure and Human Immunodeficiency Virus Infection: Integrating Women's and Children's Needs.

Authors:  V Breitbart; W Chavkin; C Layton; P Wise
Journal:  Bull N Y Acad Med       Date:  1994
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.